Intravenous Substance Abuse

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-10-19
Clinical Trial Update: Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient Transition [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating dalbavancin for treating SUD-associated infections to enable outpatient transition was terminated.